IMMUTEP Ltd (IMMP) stock
IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
$3.48−0.17 (-4.79%)
Close on Nov 13, 2026Market cap $25.64MP/E –Yield –
Immutep cash
Cash and short-term investments held at the end of each period.
Immutep's cash was A$63.67M at Jun 30, 2026. For fiscal 2026 it was A$63.67M, down 5.5% from the year before. Over ten years it grew 11.8% a year on average. The highest annual figure on record is A$161.79M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | A$63.67M | -5.5% |
| FY2025 | Jun 30, 2025 | A$67.41M | -58.3% |
| FY2024 | Jun 30, 2024 | A$161.79M | +31.1% |
| FY2023 | Jun 30, 2023 | A$123.42M | +54.3% |
| FY2022 | Jun 30, 2022 | A$80.00M | +32.0% |
| FY2021 | Jun 30, 2021 | A$60.59M | +130.2% |
| FY2020 | Jun 30, 2020 | A$26.32M | +58.9% |
| FY2019 | Jun 30, 2019 | A$16.57M | -29.4% |
| FY2018 | Jun 30, 2018 | A$23.48M | +91.8% |
| FY2017 | Jun 30, 2017 | A$12.24M | -41.4% |
| FY2016 | Jun 30, 2016 | A$20.88M | +208.9% |
| FY2015 | Jun 30, 2015 | A$6.76M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | A$63.67M | -20.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$67.41M | +11.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$161.79M | +514.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$123.42M | +644.9% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$80.00M | +240.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$60.59M | +395.2% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | A$26.32M | +26.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | A$16.57M | +145.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | A$23.48M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | A$12.24M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | A$20.88M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | A$6.76M | – |
See a number that looks wrong?